QQQ   426.76 (+0.22%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   426.76 (+0.22%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   426.76 (+0.22%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   426.76 (+0.22%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
Free Trial

Corbus Pharmaceuticals (CRBP) Earnings Date, Estimates & Call Transcripts

→ IRS Loophole Gives Americans An Escape From Inflation (From Birch Gold) (Ad)
Free CRBP Stock Alerts
$37.03
-0.13 (-0.35%)
(As of 10:47 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Mar. 12)
-$1.81 Beat By $0.55
Consensus EPS
(Mar. 12)
-$2.36
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

CRBP Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CRBP Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Corbus Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate:($5.21) EPS
Next Year EPS Consensus Estimate: ($5.12) EPS

CRBP Earnings Date and Information

Corbus Pharmaceuticals last posted its earnings results on March 12th, 2024. The biopharmaceutical company reported ($1.81) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.36) by $0.55. Corbus Pharmaceuticals has generated ($10.37) earnings per share over the last year (($10.37) diluted earnings per share). Earnings for Corbus Pharmaceuticals are expected to grow in the coming year, from ($5.21) to ($5.12) per share. Corbus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Corbus Pharmaceuticals Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)		------- 
3/12/2024Q4 2023($2.36)($1.81)+$0.55($1.81)--
11/7/2023Q3 2023($2.06)($2.27)($0.21)($2.27)--
8/8/2023Q2 2023($3.10)($2.05)+$1.05($2.05)--
5/9/2023Q1 2023($4.09)($4.24)($0.15)($4.24)--
3/7/2023Q4 2022($2.10)($2.61)($0.51)($2.61)--
11/8/2022Q3 2022($0.06)($0.07)($0.01)($0.07)--
8/9/2022Q2 2022($0.06)($0.07)($0.01)($0.03)--
5/10/2022Q1 2022($0.09)($0.08)+$0.01($0.08)--    
3/8/2022Q4 2021($0.11)($0.08)+$0.03($0.08)--
11/12/2021Q3 2021($0.12)($0.02)+$0.10($0.02)$0.81 million$0.10 million
8/12/2021Q2 2021($0.12)($0.15)($0.03)($0.15)$0.83 million$0.14 million
5/13/2021Q1 2021($0.15)($0.14)+$0.01($0.14)$0.95 million$0.65 million  

Corbus Pharmaceuticals Earnings - Frequently Asked Questions

When is Corbus Pharmaceuticals's earnings date?

Corbus Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on CRBP's earnings history.

Did Corbus Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Corbus Pharmaceuticals (NASDAQ:CRBP) reported ($1.81) earnings per share (EPS) to beat the analysts' consensus estimate of ($2.36) by $0.55. Learn more on analysts' earnings estimate vs. CRBP's actual earnings.

How much revenue does Corbus Pharmaceuticals generate each year?

Corbus Pharmaceuticals (NASDAQ:CRBP) has a recorded annual revenue of $880,000.00.

How much profit does Corbus Pharmaceuticals generate each year?

Corbus Pharmaceuticals (NASDAQ:CRBP) has a recorded net income of -$44.60 million. CRBP has generated -$10.37 earnings per share over the last four quarters.

What is Corbus Pharmaceuticals's EPS forecast for next year?

Corbus Pharmaceuticals's earnings are expected to grow from ($5.21) per share to ($5.12) per share in the next year.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:CRBP) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
IRS Loophole Gives Americans An Escape From Inflation
Birch Gold
The “Perfect Storm” for Gold
Gold Safe Exchange
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning
American Hartford Gold Group